Previous scans
Comments
-
Shrinkage
Good stuff - keep it up.0 -
12%alice124 said:12% Reduction
That's great news and, hopefully, only the first of many more reductions! I'm really happy for you. YES YES YES!!!
Thats FANTASTIC! I've had bumps and bruises that are still present after 6 weeks! Keep going! Even stable is good news. 12% is awesome. I've been told sometimes it takes 2-3 infusions before changes.0 -
You are the fortunate few!
Great news, glad to hear it.
I was on PD-1 (MDX-1106) (no Sutent) from May2011 to Jan 2012. No side effects. My notes say results are usually seen after 1st or 2nd scan. Side-effects, if at all, take 1-3mo. I had to leave the trial due to slight progression.
But I was quite content to have 7 months of side-effect free stability!
I'm on sutent now.
May you keep shrinking!
Max0 -
SwitchingMax Power said:You are the fortunate few!
Great news, glad to hear it.
I was on PD-1 (MDX-1106) (no Sutent) from May2011 to Jan 2012. No side effects. My notes say results are usually seen after 1st or 2nd scan. Side-effects, if at all, take 1-3mo. I had to leave the trial due to slight progression.
But I was quite content to have 7 months of side-effect free stability!
I'm on sutent now.
May you keep shrinking!
Max
Max, you seem to have a well-balanced attitude so I'm happy to ask you about the rationale for the exit from the trial.
I'm not so cynical as to suppose that it's designed to manipulate the apparent success figures of the trial! I imagine that the exit criteria are ethically based on factors such as toleration (the cure being worse than the disease) or progression, suggesting that it hasn't worked/has stopped working and accordingly trying something else is now in the patient's best interests. Is this correct?
Both of those criteria seem problematical and I presume medical science is, necessarily, feeling its way with these new therapies. Switching, however, seems a good idea on several grounds. First, it may wrong-foot the cancer in its endeavour to adadpt and survive (I'm using a teleological description here just as shorthand rather than with tacit assumptions).
Next, a break from a given therapy may not be permanent - sometimes success is enjoyed on a re-visit to an earlier therapy, the patient having had a refractory period in which to recover from side-effects. Then, again, we may not yet know enough, for certain, about the latencies to benefits and to side-effects - the information you give above is probably the best guess so far but we are all so different and there may be delayed benefits for some patients that we don't yet know about and that may be camouflaged by the change of regimen.
I'd be interested in your thoughts on the above (and the rationale of the decision) but, in any case, I take the opportunity to wish you every success on Sutent. Though not as new as the PD1, it's still pretty new and all indications are that it can be very effective.0 -
switchingTexas_wedge said:Switching
Max, you seem to have a well-balanced attitude so I'm happy to ask you about the rationale for the exit from the trial.
I'm not so cynical as to suppose that it's designed to manipulate the apparent success figures of the trial! I imagine that the exit criteria are ethically based on factors such as toleration (the cure being worse than the disease) or progression, suggesting that it hasn't worked/has stopped working and accordingly trying something else is now in the patient's best interests. Is this correct?
Both of those criteria seem problematical and I presume medical science is, necessarily, feeling its way with these new therapies. Switching, however, seems a good idea on several grounds. First, it may wrong-foot the cancer in its endeavour to adadpt and survive (I'm using a teleological description here just as shorthand rather than with tacit assumptions).
Next, a break from a given therapy may not be permanent - sometimes success is enjoyed on a re-visit to an earlier therapy, the patient having had a refractory period in which to recover from side-effects. Then, again, we may not yet know enough, for certain, about the latencies to benefits and to side-effects - the information you give above is probably the best guess so far but we are all so different and there may be delayed benefits for some patients that we don't yet know about and that may be camouflaged by the change of regimen.
I'd be interested in your thoughts on the above (and the rationale of the decision) but, in any case, I take the opportunity to wish you every success on Sutent. Though not as new as the PD1, it's still pretty new and all indications are that it can be very effective.
I guess my onc summed it up best: If you are progressing on [whatever] you don't want to be taking it.
My dim impression is that switching due to side-effects is often a decision of the patient (though I was told if I lose any more weight... or if my BP goes any higher...) whereas even the slightest progression (mine was miniscule) is more objective and defined by the drug co (for trials).
It is also my dim impression that once I leave a clinical trial, the drug won't be avail to me to try again until/unless it is FDA released.0 -
another thingMax Power said:switching
I guess my onc summed it up best: If you are progressing on [whatever] you don't want to be taking it.
My dim impression is that switching due to side-effects is often a decision of the patient (though I was told if I lose any more weight... or if my BP goes any higher...) whereas even the slightest progression (mine was miniscule) is more objective and defined by the drug co (for trials).
It is also my dim impression that once I leave a clinical trial, the drug won't be avail to me to try again until/unless it is FDA released.
I haven't asked, but sometimes I think that, because I'm asymptomatic, the objective is to simply keep the lesions as small as possible. As of today, if I were to stop taking any drug, I would feel great for awhile at least. That is an enviable state compared to some the docs have seen.
To wait a bit to see if the new drug will take hold is against that philosophy.0 -
discontinuation of trialTexas_wedge said:Switching
Max, you seem to have a well-balanced attitude so I'm happy to ask you about the rationale for the exit from the trial.
I'm not so cynical as to suppose that it's designed to manipulate the apparent success figures of the trial! I imagine that the exit criteria are ethically based on factors such as toleration (the cure being worse than the disease) or progression, suggesting that it hasn't worked/has stopped working and accordingly trying something else is now in the patient's best interests. Is this correct?
Both of those criteria seem problematical and I presume medical science is, necessarily, feeling its way with these new therapies. Switching, however, seems a good idea on several grounds. First, it may wrong-foot the cancer in its endeavour to adadpt and survive (I'm using a teleological description here just as shorthand rather than with tacit assumptions).
Next, a break from a given therapy may not be permanent - sometimes success is enjoyed on a re-visit to an earlier therapy, the patient having had a refractory period in which to recover from side-effects. Then, again, we may not yet know enough, for certain, about the latencies to benefits and to side-effects - the information you give above is probably the best guess so far but we are all so different and there may be delayed benefits for some patients that we don't yet know about and that may be camouflaged by the change of regimen.
I'd be interested in your thoughts on the above (and the rationale of the decision) but, in any case, I take the opportunity to wish you every success on Sutent. Though not as new as the PD1, it's still pretty new and all indications are that it can be very effective.
Tex / Max,
Interesting discussion. Thanks for having it.
“I'm not so cynical as to suppose that it's designed to manipulate the apparent success figures of the trial!” An AHA moment for me!
Being green and relatively new to the trial world, it’s not something that would have occurred to me. But thought and possibility is probably something to keep in the back of mind.
Tex-thanks for mentioning it even if not supposing it.0 -
Painalice124 said:12%
Tac - just wondering if any of the pain has subsided with reduction?
Yes I have had some pain flare ups in the chest stop happening. A few times a day my chest would hurt drastically but haven't had them since 3 weeks into trial. The leg pain is unchanged since no reduction there. Alice, I didn't know if you had seen that Monica told me wrong on dosage that I was receiving , I am getting 5 mg dose.0 -
dosagetacyarts said:Pain
Yes I have had some pain flare ups in the chest stop happening. A few times a day my chest would hurt drastically but haven't had them since 3 weeks into trial. The leg pain is unchanged since no reduction there. Alice, I didn't know if you had seen that Monica told me wrong on dosage that I was receiving , I am getting 5 mg dose.
Yes I did see that. I believe that's the highest dosage now (at Hopkins). The maximum dosage started out at 10 mg but then was changed to 5 mg (remember John signing an addendum reducing the max dosage from 10 mg to 5 mg even though it did not directly impact him.) He's on 2 mg, what they refer to as the active dose. He too has been told the bone mets are much slower to respond. He has his next scan on Wednesday, 10/24/12. Keeping our fingers crossed.
I assume you're still unable to work. What kind of work do you do?0 -
Alice, just wondering. Didalice124 said:dosage
Yes I did see that. I believe that's the highest dosage now (at Hopkins). The maximum dosage started out at 10 mg but then was changed to 5 mg (remember John signing an addendum reducing the max dosage from 10 mg to 5 mg even though it did not directly impact him.) He's on 2 mg, what they refer to as the active dose. He too has been told the bone mets are much slower to respond. He has his next scan on Wednesday, 10/24/12. Keeping our fingers crossed.
I assume you're still unable to work. What kind of work do you do?
Alice, just wondering. Did they give John radiation for the bone mets? I hear radiation really helps them disappear faster and greatly helps the pain. If they didnt' offer it to him for the bones, is there a possibility of asking for it? Fox has done well with it! All my best to you and John!0 -
agree lolalice124 said:discontinuation of trial
Tex / Max,
Interesting discussion. Thanks for having it.
“I'm not so cynical as to suppose that it's designed to manipulate the apparent success figures of the trial!” An AHA moment for me!
Being green and relatively new to the trial world, it’s not something that would have occurred to me. But thought and possibility is probably something to keep in the back of mind.
Tex-thanks for mentioning it even if not supposing it.
That's why there is intention-to-treat analysis in biostatistics. So RCT that use ITT analysis is more transparent0 -
radiationangec said:Alice, just wondering. Did
Alice, just wondering. Did they give John radiation for the bone mets? I hear radiation really helps them disappear faster and greatly helps the pain. If they didnt' offer it to him for the bones, is there a possibility of asking for it? Fox has done well with it! All my best to you and John!
They did briefly mention it at one point but then quickly dismissed the idea, saying it was off protocol for the trial.
Since he has done pretty well managing with pain oxy***es, he hasn't pushed the issue. He also attributes the oxycodone/oxycontin to his NOT experiencing the diarrhea that often accompanies of use of Votrient, since the oxy***s are basically immodium with opiates.0 -
agreeClaraW said:agree lol
That's why there is intention-to-treat analysis in biostatistics. So RCT that use ITT analysis is more transparent
Clara, before I get back to you re the brilliant research work you've done on my behalf, a quick question:
Have you come across and if so would you recommend a book from 2010 - James Penston's Stats.con: How We've Been Fooled by Statistics-Based Research in Medicine?0 -
I understand. I was onalice124 said:radiation
They did briefly mention it at one point but then quickly dismissed the idea, saying it was off protocol for the trial.
Since he has done pretty well managing with pain oxy***es, he hasn't pushed the issue. He also attributes the oxycodone/oxycontin to his NOT experiencing the diarrhea that often accompanies of use of Votrient, since the oxy***s are basically immodium with opiates.
I understand. I was on heavy pain meds at one point, and the runs are not the culprit.. The constipation is another thing! LOL I guess it might have done good for John to get the radiation, it would probably work quicker on eliminating the bone mets and it would be ideal to not have to take those pain meds for too long. But i guess he has to be the good patient and take what they give him. Does that mean that as long as he is on the trial his treatment regimen cannot change? I wonder if they are aware that others on very similar trials are in fact getting the radiation(like our FOX). Thank you Alice for sharing. xxoo much love to you!0 -
stats con?Texas_wedge said:agree
Clara, before I get back to you re the brilliant research work you've done on my behalf, a quick question:
Have you come across and if so would you recommend a book from 2010 - James Penston's Stats.con: How We've Been Fooled by Statistics-Based Research in Medicine?
Sorry, I haven't come across this book. I guess if you'd like to know how to critically appraise a trial, there's better tools (guidelines) out there which are only a couple of pages to read. I rarely read big books nowadays . I've read very little on statistics and know hardly anything about research, thus my understanding in this area is very very superficial.0 -
Workalice124 said:dosage
Yes I did see that. I believe that's the highest dosage now (at Hopkins). The maximum dosage started out at 10 mg but then was changed to 5 mg (remember John signing an addendum reducing the max dosage from 10 mg to 5 mg even though it did not directly impact him.) He's on 2 mg, what they refer to as the active dose. He too has been told the bone mets are much slower to respond. He has his next scan on Wednesday, 10/24/12. Keeping our fingers crossed.
I assume you're still unable to work. What kind of work do you do?
I've owned a restaurant named The Stray Cat Cafe for 17 years now in Moorefield WV. I am putting so much exta work on my wife's shoulders by me being sick, she is a trooper!!0 -
Workalice124 said:dosage
Yes I did see that. I believe that's the highest dosage now (at Hopkins). The maximum dosage started out at 10 mg but then was changed to 5 mg (remember John signing an addendum reducing the max dosage from 10 mg to 5 mg even though it did not directly impact him.) He's on 2 mg, what they refer to as the active dose. He too has been told the bone mets are much slower to respond. He has his next scan on Wednesday, 10/24/12. Keeping our fingers crossed.
I assume you're still unable to work. What kind of work do you do?
I've owned a restaurant named The Stray Cat Cafe for 17 years now in Moorefield WV. I am putting so much exta work on my wife's shoulders by me being sick, she is a trooper!!0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.9K Cancer specific
- 2.8K Anal Cancer
- 446 Bladder Cancer
- 309 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 398 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.4K Kidney Cancer
- 671 Leukemia
- 794 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 237 Multiple Myeloma
- 7.1K Ovarian Cancer
- 63 Pancreatic Cancer
- 487 Peritoneal Cancer
- 5.5K Prostate Cancer
- 1.2K Rare and Other Cancers
- 540 Sarcoma
- 734 Skin Cancer
- 654 Stomach Cancer
- 191 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.9K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards